Development of MPO-ANCA-related Vasculitis in Systemic Sclerosis: Report of Two Cases and Review of the Literature
-
- Makinodan Eri
- Department of Dermatology, Nara Medical University School of Medicine
-
- Kobayashi Nobuhiko
- Department of Dermatology, Nara Medical University School of Medicine
-
- Hoshino Sachiko
- Department of Dermatology, Nara Medical University School of Medicine
-
- Izumi Atsuko
- Department of Dermatology, Nara Medical University School of Medicine
-
- Yokoi Shoko
- Department of Dermatology, Nara Medical University School of Medicine
-
- Yamamoto Yoshiteru
- Department of Dermatology, Nara Medical University School of Medicine
-
- Asada Hideo
- Department of Dermatology, Nara Medical University School of Medicine
-
- Asai Osamu
- First Department of Internal Medicine, Nara Medical University School of Medicine
-
- Nakatani Kimihiko
- First Department of Internal Medicine, Nara Medical University School of Medicine
-
- Kumamoto Makiko
- Second Department of Internal Medicine, Nara Medical University School of Medicine
-
- Suzaki Yasue
- Second Department of Internal Medicine, Nara Medical University School of Medicine
-
- Hamada Kaoru
- Second Department of Internal Medicine, Nara Medical University School of Medicine
-
- Miyagawa Sachiko
- Department of Dermatology, Nara Medical University School of Medicine
Bibliographic Information
- Other Title
-
- MPO-ANCA関連血管炎と全身性強皮症:半月体形成性糸球体腎炎,多発単神経炎を合併した全身性強皮症の2例の検討と文献的考察
- MPO ANCA カンレン ケッカンエン ト ゼンシンセイ キョウヒショウ ハンゲツタイ ケイセイセイ シキュウタイジンエン タハツタンシンケイエン オ ガッペイ シタ ゼンシンセイ キョウヒショウ ノ 2レイ ノ ケントウ ト ブンケンテキ コウサツ
Search this article
Description
We report two patients, a 59-year-old female and a 21-year-old female with systemic sclerosis (SSc) who demonstrated myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA). Both patients developed crescentic glomerulonephritis and mononeuritis multiplex, respectively, nine years after the onset of SSc. We diagnosed these patients as having an overlap of SSc and MPO-ANCA-related vasculitis. A combination of oral administration of prednisolone and intravenous cyclophosphamide improved their vasculitic symptoms. We determined the incidence of ANCA-related vasculitis in SSc patients at our hospital. Of the 21 SSc patients examined, only the two patients described here were MPO-ANCA positive. A literature review demonstrated that the features of Japanease SSc patients who produce MPO-ANCA included a high incidence of positive anti-topoisomerase I antibody (71%) and a long lag phase between the onset of SSc and the development of MPO-ANCA (average 10 years, 0.5~30 years). Although the development of MPO-ANCA-related vasculitis is extremely rare in SSc patients, it is clinically of great importance. Acute progressive glomerulonephritis as well as pulmonary hemorrhage caused by ANCA-related vasculitis can determine the prognosis of such patients. If clinically evident vasculitis occurs in an SSc patient, particularly a patient with positive anti-topoisomerase I antibody and a long lag phase from the onset of SSc, prompt diagnosis of ANCA-related vasculitis and the early initiation of immunosuppressive therapy, particularly in the case of life-threatening conditions, can be determinative factors for a good outcome.
Journal
-
- The Japanese Journal of Dermatology
-
The Japanese Journal of Dermatology 116 (1), 51-60, 2006
Japanese Dermatological Association
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001205739803520
-
- NII Article ID
- 130004708404
- 10017562201
-
- NII Book ID
- AN00196602
-
- ISSN
- 13468146
- 0021499X
-
- NDL BIB ID
- 7823257
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- CiNii Articles
-
- Abstract License Flag
- Disallowed